Unregistered Sales of Equity Securities and Use of Proceeds
+Added: Issuances of Common Stock upon the Exercise of Warrants
+Added: On January 15, 2021, we issued 388,119 shares of our common stock to one warrantholder upon the net exercise of warrants.
+Added: The issuance of these securities was exempt from registration under Section 3(a)(9) of the Securities Act.
Amended and Restated Certificate of Incorporation of the Registrant (incorporated herein by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No.
2 unchanged sentences
001-37581), filed with the SEC on June 24, 2020).
−Removed: Purchase Agreement, dated as of August 13, 2020, by and between the Registrant and Lincoln Park Capital Fund, LLC .
−Removed: (incorporated herein by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-37581), filed with the SEC on August 13, 2020).
−Removed: Registration Rights Agreement, dated as of August 13, 2020, by and between the Registrant and Lincoln Park Capital Fund, LLC .
−Removed: (incorporated herein by reference to Exhibit 10.2 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-37581), filed with the SEC on August 13, 2020).
Certification of Principal Executive Officer under Section 302 of the Sarbanes-Oxley Act.
13 unchanged sentences
ACLARIS THERAPEUTICS, INC.
−Removed: November 4, 2020
/s/ Neal Walker
1 unchanged sentence
(On behalf of the Registrant)
−Removed: November 4, 2020
/s/ Frank Ruffo
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.